ID
38187
Descrizione
Study ID: 111539 Clinical Study ID: 111539 Study Title: A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of scalating Repeat Doses of GSK249320 in Patients With Stroke Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00833989 https://clinicaltrials.gov/ct2/show/NCT00833989 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Refanezumab, Placebo Trade Name: N/A Study Indication: Ischaemic Attack, Transient The study consists of 8 visits: Day 1, Week 1 (Day 5), Week 2 (Day 10), Week 4 (Day 30), Week 8 (Day 60), Week 12 (Day 90), Week 16 (Day 112), Follow-up (F/U). All subjects will receive two doses. The first dose within 24-72 hrs after stroke the second dose 9 +/- 1 days after the first one. Each dose will be given as an intravenous infusion over 60 minutes. This document contains the Vital Signs form. It has to be filled in for: Day 1, Week 1, Week 2, Week 4, Week 8, Week 12, Week 16, early withdrawal, if necessary as unscheduled form as well as for logs/repeats.
collegamento
https://clinicaltrials.gov/ct2/show/NCT00833989
Keywords
versioni (1)
- 25/09/19 25/09/19 -
Titolare del copyright
GlaxoSmithKline
Caricato su
25 settembre 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Safety, Pharmacokinetics and Pharmacodynamics of Refanezumab in Patients with Stroke, NCT00833989
Vital Signs
- StudyEvent: ODM
Descrizione
Dosing Date and Time
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0178602
- UMLS CUI-3
- C0011008
- UMLS CUI-4
- C0040223
Descrizione
Height and Weight
Alias
- UMLS CUI-1
- C0005890
- UMLS CUI-2
- C0005910
Descrizione
Vital Signs
Alias
- UMLS CUI-1
- C0518766
Descrizione
For repeat measurements only.
Tipo di dati
integer
Alias
- UMLS CUI [1]
- C2348184
Descrizione
Note: Time "0 min" is Immediately prior to start of infusion; Time "1 hr" is immediately after infusion has stopped. Day 1 and Week 2 only; up until 1 hour post start of infusion all times for both visits, on Day 1 additionally at 2, 4, 8, 12 and 24 hours post start of infusion, in Week 2 only the 3 hours measurement in addition
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0574032
Descrizione
day month year
Tipo di dati
date
Alias
- UMLS CUI [1]
- C0011008
Descrizione
00:00-23:59
Tipo di dati
time
Alias
- UMLS CUI [1]
- C0040223
Descrizione
Vitals to be taken in supine position.
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Descrizione
Vitals to be taken in supine position.
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1]
- C0428883
Descrizione
Vitals to be taken in supine position.
Tipo di dati
integer
Unità di misura
- beats/min
Alias
- UMLS CUI [1]
- C0018810
Similar models
Vital Signs
- StudyEvent: ODM
C0178602 (UMLS CUI-2)
C0011008 (UMLS CUI-3)
C0040223 (UMLS CUI-4)
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0574032 (UMLS CUI [1,2])